Mandate

Vinge advises iZettle in connection with capital procurement ahead of international expansion

June 25, 2012

Vinge has advised iZettle and its founders in connection with a capital raising of approximately EUR 25 million from a number of venture capital investors including, among others, Greylock Partners, Index Ventures and Creandum and MasterCard. iZettle’s service consists of an app with chip card that turns an iPhone, iPad or iPod Touch into a mobile payment terminal. iZettle’s services are currently available in Sweden, Norway, Denmark, Finland and Great Britain and the company will use the additional funds to expand into additional international markets.

Vinge’s team consisted of, among others, partner Henrik Wenckert and associates Kristina Ekberg and Maria Eierborg as well as project assistant Maria Ikonomou. Advokat Dan Hanqvist and associate Katarina Rykowska advised on regulatory issues.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026